Het Vyas

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Positive Breast Cancer

Tyrosine Kinase

Top Venues

Journal of medicinal chemistry

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Rudradip Das, Priyanka Pulugu, Aditya A Singh, Deep Rohan Chatterjee, Shraddha Baviskar, Het Vyas, Santosh Kumar Behera, Akshay Srivastava, Hemant Kumar, Amit Shard
Mechanistic Investigation of Thiazole-Based Pyruvate Kinase M2 Inhibitor Causing Tumor Regression in Triple-Negative Breast Cancer. Journal of medicinal chemistry 67 (5) (2024)
Rudradip Das, Priyanka Pulugu, Aditya A Singh, Deep Rohan Chatterjee, Shraddha Baviskar, Het Vyas, Santosh Kumar Behera, Akshay Srivastava, Hemant Kumar, Amit Shard
Mechanistic Investigation of Thiazole-Based Pyruvate Kinase M2 Inhibitor Causing Tumor Regression in Triple-Negative Breast Cancer. Journal of medicinal chemistry (2024)
Rudradip Das, Priyanka Pulugu, Aditya A Singh, Deep Rohan Chatterjee, Shraddha Baviskar, Het Vyas, Santosh Kumar Behera, Akshay Srivastava, Hemant Kumar, Amit Shard
Mechanistic Investigation of Thiazole-Based Pyruvate Kinase M2 Inhibitor Causing Tumor Regression in Triple-Negative Breast Cancer. Journal of medicinal chemistry 67 (5) (2024)
Rudradip Das, Deep Rohan Chatterjee, Saumya Kapoor, Het Vyas, Amit Shard
Novel sulfonamides unveiled as potent anti-lung cancer agents via tumor pyruvate kinase M2 activation. RSC medicinal chemistry 15 (9) (2024)